New Transplant Technique Restores Vision in Mice

Summary: Researchers transplant retinas derived from stem cells to restore vision in mice.

Source: RIKEN.

Researchers at the RIKEN Center for Developmental Biology in Kobe, Japan have shown that retinal transplants derived from induced pluripotent stem cells (iPSCs) can restore visual function in mice. Published in Stem Cell Reports, the study shows that neurons in the implanted retinal sheets integrate well with the host, respond to light, and send their signals to the brain as judged by behavioral experiments.

Retinal degeneration is mostly a hereditary disease that is characterized by the death of photoreceptors—the light-sensitive neurons in the eye—which eventually leads to blindness. While many have attempted to treat the disease through retinal transplants, and some have shown that transplanting graft photoreceptors to the host without substantial integration can rescue retinal function, until now, no one has conclusively succeeded in transplanting photoreceptors that functionally connect to host cells and send visual signals to the host retina and brain.

The team led by Masayo Takahashi studied this problem using a mouse model for end-stage retinal degeneration in which the outer nuclear layer of the retina is completely missing. This is an important issue because in clinical practice this type of therapy would most likely target end-stage retinas in which of the photoreceptors are dead and the next neurons up the chain do not have any input.

The Takahashi group has recently shown that 3D retinal sheets derived from mouse embryonic stem cells develop normal structure connectivity. “Using this method was a key point,” explains first author Michiko Mandai, “Transplanting retinal tissue instead of simply using photoreceptor cells allowed the development of more mature, organized morphology, which likely led to better responses to light.”

In order to assess the success of the transplantations, the team integrated some modifications to the retinal sheets and the model mice. They used a fluorescent protein to label the ends of the photoreceptors, which is where they would connect to the host neurons—the bipolar retinal cells—and ultimately the brain. After labeling the host retinal bipolar cells with a different fluorescent protein, they found that the labeled cell terminals from the graft did indeed make contact with the cells labeled in the host, indicating that the newly grown photoreceptors naturally connected themselves to the bipolar cells in the model mice.

To assess whether the mice could see light, the researchers used a behavioral learning task. Mice with normal vision can learn to associate sounds or light with different events, the same way that Pavlov’s famous dog associated food with the sound of a bell. While the model mice who lacked a photoreceptor layer in their retinas could not learn to associate anything with light before surgery, they could after the transplant, provided that a substantial amount of the transplant was located in the correct place. This means that not only did the new cells in the retina respond to light, but the information traveled to the brain and could be used normally to learn.

Image shows bipolar cells.

3D observation of contact between GFP-positive host bipolar cells (green) and CtBP2-tdTomato in the graft outer nuclear layer (red). DAPI marks the cell bodies of the graft retinal sheet. NeuroscienceNews.com image is credited to the researchers.

“These results are a proof of concept for using iPSC-derived retinal tissue to treat retinal degeneration,” says Mandai. “We are planning to proceed to clinical trials in humans after a few more necessary studies using human iPSC-derived retinal tissue in animals. Clinical trials are the only way to determine how many new connections are needed for a person to be able to ‘see’ again.”

Although the results are promising, Mandai cautions that for now this therapy is at the developmental stage. “We cannot expect to restore practical vision at the moment,” She explains. “We will start from seeing a simple light, then possibly move on to larger figures in the next stage.”

About this visual neuroscience research article

Source: Adam Phillips – RIKEN
Image Source: NeuroscienceNews.com image is credited to the researchers.
Original Research: Full open access research for “iPSC-derived retinal transplants improve vision in rd1 end-stage retinal degeneration mice” by Michiko Mandai, Momo Fujii, Tomoyo Hashiguchi, Genshiro A. Sunagawa, Shinichiro Ito, Jianan Sun, Jun Kaneko, Junki Sho, Chikako Yamada, and Masayo Takahashi in Stem Cell Reports. Published online January 10 2017 doi:10.1016/j.stemcr.2016.12.008

Cite This NeuroscienceNews.com Article
RIKEN “New Transplant Technique Restores Vision in Mice.” NeuroscienceNews. NeuroscienceNews, 12 January 2017.
<http://neurosciencenews.com/transplant-vision-restoration-5930/>.
RIKEN (2017, January 12). New Transplant Technique Restores Vision in Mice. NeuroscienceNew. Retrieved January 12, 2017 from http://neurosciencenews.com/transplant-vision-restoration-5930/
RIKEN “New Transplant Technique Restores Vision in Mice.” http://neurosciencenews.com/transplant-vision-restoration-5930/ (accessed January 12, 2017).

Abstract

iPSC-derived retinal transplants improve vision in rd1 end-stage retinal degeneration mice

Highlights

•iPSC retina reconstructs outer nuclear layer in the end-stage retina
•Contacts between the host bipolar cells and graft photoreceptors were visualized
•rd1 mice became responsive to light after iPSC-retina transplantation
•RGC responses to light were recorded from host rd1 retina after transplantation

Summary
Recent success in functional recovery by photoreceptor precursor transplantation in dysfunctional retina has led to an increased interest in using embryonic stem cell (ESC) or induced pluripotent stem cell (iPSC)-derived retinal progenitors to treat retinal degeneration. However, cell-based therapies for end-stage degenerative retinas that have lost the outer nuclear layer (ONL) are still a big challenge. In the present study, by transplanting mouse iPSC-derived retinal tissue (miPSC retina) in the end-stage retinal-degeneration model (rd1), we visualized the direct contact between host bipolar cell terminals and the presynaptic terminal of graft photoreceptors by gene labeling, showed light-responsive behaviors in transplanted rd1 mice, and recorded responses from the host retina with transplants by ex vivo micro-electroretinography and ganglion cell recordings using a multiple-electrode array system. Our data provides a proof of concept for transplanting ESC/iPSC retinas to restore vision in end-stage retinal degeneration.

“iPSC-derived retinal transplants improve vision in rd1 end-stage retinal degeneration mice” by Michiko Mandai, Momo Fujii, Tomoyo Hashiguchi, Genshiro A. Sunagawa, Shinichiro Ito, Jianan Sun, Jun Kaneko, Junki Sho, Chikako Yamada, and Masayo Takahashi in Stem Cell Reports. Published online January 10 2017 doi:10.1016/j.stemcr.2016.12.008

Feel free to share this Neuroscience News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.com
We hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.
No more articles